On February 27, 2024, Philippines Food and Drug Administration (FDA) initiated a consultation on a new draft of Prescribing the Rules, Requirements and Procedures in the Application for License to Operate of Covered Health Product Establishments with the Food and Drug Administration Repealing for the Purpose Administrative Order No. 2020-0017. Compared to previous draft amendments, the new draft primarily updates the requirements and validities for LTO applications, and further clarifies FDA's decision grounds for these applications.